Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Getting new auth cookie, if you see this message a lot, tell someone!
  • Getting new auth cookie, if you see this message a lot, tell someone!
  • Getting new auth cookie, if you see this message a lot, tell someone!

Diabetes

  • You have access
    Continuous glucose monitoring: High-tech devices still need some low-tech backup
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2024, 91 (10) 585-586; DOI: https://doi.org/10.3949/ccjm.91b.10024

    High-end devices that monitor patients’ physiology offer many benefits, but device malfunctions and disruptions are not rare events.

  • You have access
    Using continuous glucose monitoring data in daily clinical practice
    Thomas W. Martens, MD, Gregg D. Simonson, PhD and Richard M. Bergenstal, MD
    Cleveland Clinic Journal of Medicine October 2024, 91 (10) 611-620; DOI: https://doi.org/10.3949/ccjm.91a.23090

    The authors review data elements of the Ambulatory Glucose Profile Report, a standardized format for displaying glucose monitoring data, and present a structured approach to using the data to optimize glycemic management.

  • Diabetic retinopathy: Screening, prevention, and treatment
    You have access
    Diabetic retinopathy: Screening, prevention, and treatment
    David D. Chong, BA, Nikhil Das, MD and Rishi P. Singh, MD
    Cleveland Clinic Journal of Medicine August 2024, 91 (8) 503-510; DOI: https://doi.org/10.3949/ccjm.91a.24028

    Effective screening processes, timely referrals, and strategic diabetes management are essential to prevent and mitigate the consequences of diabetic retinopathy.

  • You have access
    SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2024, 91 (7) 392-393; DOI: https://doi.org/10.3949/ccjm.91b.07024

    What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?

  • SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
    You have access
    SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
    Rahul Jaswaney, MD, Samantha Sokoloff, MD, Val Rakita, MD and Daniel J. Rubin, MD, MSc
    Cleveland Clinic Journal of Medicine July 2024, 91 (7) 415-423; DOI: https://doi.org/10.3949/ccjm.91a.23093

    This review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.

  • Diabetes technology: A primer for clinicians
    You have access
    Diabetes technology: A primer for clinicians
    Jayachidambaram Ambalavanan, MD, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine June 2024, 91 (6) 353-360; DOI: https://doi.org/10.3949/ccjm.91a.23073

    This review of the basics of various diabetes management devices is intended to enhance clinicians’ comfort level in helping patients use these technologies.

  • You have access
    Acquired reactive perforating collagenosis in a patient with diabetes
    Li-wen Zhang, MD, Juan Wu, MD, PhD, Rong-hua Xu, MD and Tao Chen, MD, PhD
    Cleveland Clinic Journal of Medicine April 2024, 91 (4) 213-214; DOI: https://doi.org/10.3949/ccjm.91a.23074

    A 47-year-old woman presented with a 2-month history of pruritic eruptions on the left ankle and a complaint of thirst and polyuria for the past year.

  • You have access
    In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
    Pooja Prasad, MD and Megha Prasad, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82-83; DOI: https://doi.org/10.3949/ccjm.91c.02002
  • You have access
    Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82; DOI: https://doi.org/10.3949/ccjm.91c.02001
  • You have access
    Stiff hands in a man with type 1 diabetes
    Rhea Ahuja, MD and Purn Pragya, MBBS
    Cleveland Clinic Journal of Medicine December 2023, 90 (12) 721-722; DOI: https://doi.org/10.3949/ccjm.90a.23046

    The patient had been on injectable insulin for the past 6 years, with frequent dose titrations because of poor control. A recent hemoglobin A1c was 7.2%.

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Adolescent Medicine
  • Allergy/Immunology
  • Anticoagulation
  • Cardiology
  • Covid-19
  • Critical Care
  • Dermatology
  • Diabetes
  • Drug Therapy
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • Genetics
  • Geriatrics
  • Hematology
  • Hepatology
  • Hospice & Palliative Medicine
  • Hospital Medicine
  • Imaging
  • Infectious Diseases
  • Medical Humanities
  • Medical Humanities/Ethics
  • Men's Health
  • Mental Health
  • Nephrology
  • Neurology
  • Obesity
  • Oncology
  • Pain
  • Physical Exam
  • Practice Management
  • Preventive Care
  • Pulmonology
  • Rehabilitation Medicine
  • Rheumatology
  • Sleep Medicine
  • Surgery/Surgery Subspecialties
  • Vascular Medicine
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire